Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Research Results on Jolly Good's Medical VR Will Be Presented for the First Time in the U.S. - Revealing Training VR for HALO Procedures at Large-Scale VR Seminar, SAEM2024 2024-05-08 02:00
FDA Grants Orphan Drug Designation to 9MW2821 2024-05-07 22:00
Meihua International Medical Technologies Co., Ltd. to Present at the Emerging Growth Conference on May 9, 2024 2024-05-07 21:08
GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024 2024-05-07 13:27
Datasea Pre-Announces Estimated Revenue of $12.5 Million for April 2024 Supporting its Prior Revenue Guidance of $86 Million for Fiscal 2024 2024-05-06 22:00
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease 2024-05-03 19:00
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers 2024-05-02 07:01
135th Canton Fair Showcases Leading Medical Devices, Elevating Global Health Management 2024-05-01 13:40
Jacobio Pharma Announced its KRAS G12C inhibitor reached the primary endpoint 2024-05-01 08:59
Eluminex Biosciences Announces FDA Acceptance of Investigational New Drug (IND) Application for EB-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) - and Upcoming Scientific Presentations 2024-04-30 23:00
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma 2024-04-30 20:55
A Potential First-In-Class Drug: CDE Approved Single-Arm Pivotal Clinical Study of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs 2024-04-30 20:16
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update 2024-04-30 19:00
I-MAB Filed 2023 Annual Report on Form 20-F 2024-04-30 19:00
111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow 2024-04-30 14:30
WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment 2024-04-30 10:55
Hurom Takes Global Action to Protect Juicer Patents 2024-04-29 21:00
Medit launches the revolutionary i900, an intraoral scanning system set to redefine the scanning experience for dental clinics worldwide 2024-04-29 21:00
CARsgen Submitted Responses to FDA Observations 2024-04-29 20:50
Laekna Releases 2023 ESG Report 2024-04-29 20:30
1 28 29 30 31 32 431